FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3,819 letters. Newest first.

  1. CARsgen Therapeutics Corporation

    FDA warns CARsgen over CGMP violations for investigational CAR T cell products at Durham facility.

    High risk
  2. Minland of Texas, Inc.

    FDA warned Minland of Texas that it lacked a required Foreign Supplier Verification Program for imported peanut gluten, soy sauce, and rice vinegar.

    Medium
  3. EyePoint Pharmaceuticals, Inc.

    FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.

    High risk
  4. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  5. Media Networks Sydney Pty Limited

    Media Networks Sydney failed to properly list Mylanta 2go Antacid and Microlax Enema with FDA, making them misbranded.

    Low
  6. Eugia Pharma Specialities Limited

    FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.

    High risk
  7. Intercos Europe S.p.A

    FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.

    High risk
  8. Manabi Export Panama S.A.

    FDA cited Panama seafood processor Manabi Export for missing HACCP (food-safety plan) controls on ready-to-eat cooked clam meat in reduced-oxygen packaging.

    High risk
  9. Agustson A/S

    Agustson A/S's frozen hot smoked trout fillet plan has serious seafood safety gaps, FDA says.

    High risk
  10. Virtue Vapes

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  11. P&L Bean Sprout Farm

    FDA says P&L Bean Sprout Farm's ready-to-eat mung and soybean sprouts were held under insanitary conditions, including rodent feces and falling sludge.

    High risk
  12. AUSTROFOOD S.A.S.

    Austrofood's apple cinnamon puree pouches were adulterated with extremely high lead from cinnamon; hazard controls failed.

    High risk
  13. LS Promotions Inc.

    LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.

    High risk
  14. BullyKamp Products LLC

    BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.

    High risk
  15. Top Dog Pet Store LLC dba The Bulldog Cartel

    Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.

    High risk
  16. Txsyn Int. LLC

    FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.

    Medium
  17. Globus Medical, Inc.

    FDA warns Globus Medical over Excelsius GPS robot-related misplaced screw complaints and late or missing device reports.

    High risk
  18. Nowrez & Ismail Shukri Company

    FDA warns Jordanian OTC drug maker Nowrez & Ismail Shukri over CGMP violations and import alert.

    High risk
  19. Central Admixture Pharmacy Services, Inc.

    FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.

    High risk
  20. Baylab USA, LLC

    Baylab USA sold unapproved Level 1 masks, KN95 respirators and unclear colors and kids' versions of its Level 3 mask, FDA says.

    High risk
  21. Konrad Rejdak, M.D., Ph.D.

    FDA warns Dr. Konrad Rejdak over clinical trial data integrity failures in a CIDP immune globulin study.

    Medium
  22. Dream Vapor LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  23. Alohma LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  24. Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.

    FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.

    High risk
  25. Omega Tech Labs LLC

    Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.

    High risk
  26. Velocity Pharma LLC

    Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.

    High risk
  27. La Parcela Produce LLC

    La Parcela Produce LLC lacked required U.S. importer food-safety records for imported cilantro, lettuce, poblano pepper, and jalapeno.

    Medium
  28. High Quality Organics, Inc.

    FDA warned High Quality Organics over ready-to-eat spices after finding weak pathogen controls and no pesticide-hazard reanalysis.

    High risk
  29. Global Supply Allies Inc. d/b/a Vapor Grab

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  30. Smoke and Vape Company, LLC d/b/a Smoke and Vape Co.

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  31. Smoking Vibes LLC d/b/a Smoking Vibes

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  32. Cavalry Industries d/b/a Select Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  33. HTXW LLC d/b/a FOMO Culture

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  34. Walmart, Inc.

    FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.

    High risk
  35. ISIS.GOLD

    ISIS.GOLD sells TCA 100% and Whitening SA chemical peels as unapproved new drugs without FDA-approved applications.

    High risk
  36. Skin Beauty Solutions

    FDA warns Skin Beauty Solutions that its chemical peel products are unapproved new drugs sold with acne and scar treatment claims.

    High risk
  37. Repare Skincare

    Repare Skincare sold unapproved TCA and glycolic acid chemical peels online with drug claims, FDA says.

    High risk
  38. Matte Beauty

    FDA warned Matte Beauty that its chemical peel drugs are unapproved and sold with treatment claims.

    High risk
  39. Amazon.com, Inc.

    FDA warns Amazon over selling two unapproved chemical peel drugs that can burn skin.

    High risk
  40. Corporacion Avicola Morovis Inc

    FDA warns Corporacion Avicola Morovis over Salmonella prevention failures at its Puerto Rico shell egg farm.

    High risk
  41. AMCO International Manufacturing & Design, Inc.

    AMCO International made and sold AED replacement batteries without required FDA approval, FDA says.

    High risk
  42. Alohma LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  43. Alohma LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  44. Alohma, LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  45. Alohma LLC d/b/a Kure Vaporium

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  46. Alohma LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  47. Alohma LLC d/b/a Kure CBD & Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  48. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  49. TX Smoke

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  50. Criticare Technologies, Inc.

    FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.

    High risk